secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0001104659-25-087286
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio files updated corporate presentation for investor meetings
-------------------------------------------------------------------

- Updated corporate presentation dated September 4, 2025, filed as Exhibit 99.1.
- Presentation highlights Zura Bio's dual-pathway biologic candidates in autoimmune/inflammatory diseases.
- No specific clinical, financial, or guidance changes disclosed; presentation is a routine update.
- Ticker ZURA is the sole identifier; no counterparties mentioned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465925087286/0001104659-25-087286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465925087286/tm2525151d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-087286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer